Cameco Plummets 6.4% Amid Trump Admin's Nuclear Shift, Trading Volume Soars 57.25% to $0.72B, Ranking 135th

Market Snapshot

Cameco (CCJ) fell 6.40% on March 13, 2026, closing at its lowest level in two months amid heightened uncertainty surrounding its stake in Westinghouse. The stock’s decline occurred despite a 57.25% surge in trading volume, which reached $0.72 billion—ranking 135th in the market. The sharp drop followed reports of stalled negotiations between the Trump administration and Westinghouse, the developer of the U.S. flagship nuclear reactor, prompting exploratory talks with alternative nuclear firms.

Key Drivers

The Trump administration’s reported pivot away from Westinghouse has cast a shadow over Cameco’s strategic position. Cameco holds a 49% interest in Westinghouse, which is central to the U.S. nuclear industry’s revival efforts. However, the government’s inability to secure a deal with Brookfield Asset Management, Westinghouse’s majority owner, has led to discussions with GE Vernova Hitachi Nuclear Energy and South Korea’s Korea Electric Power. These moves signal a potential shift in the administration’s support away from Westinghouse, directly impacting Cameco’s value proposition.

A critical factor in the administration’s hesitation is the absence of cost-overrun insurance in federal financing programs for new reactors. This omission raises financial risks for developers, including Westinghouse, and reduces the attractiveness of its projects compared to alternatives. The U.S. Department of Energy’s recent outreach to other firms highlights this gap, as competitors may offer more favorable terms or risk mitigation strategies. For Cameco, which relies on Westinghouse’s success to justify its long-term uranium demand, the lack of insurance exacerbates uncertainty.

The broader market context also played a role in Cameco’s performance. Major indices, including the S&P 500 and Nasdaq Composite, ended lower as investors digested mixed economic data. While Cameco’s decline was primarily driven by sector-specific news, the overall market sentiment contributed to its sharp drop. The stock’s 6.4% loss outperformed its peers, reflecting the concentrated impact of nuclear industry dynamics on its valuation.

Analyst ratings and institutional activity further underscored the stock’s volatility. MarketBeat.com noted a “Moderate Buy” consensus with a $150.40 target price, but recent institutional transactions, such as purchases by ARP Global Capital and Legal & General Group, suggest cautious optimism. These moves, however, were overshadowed by the administration’s nuclear policy shifts. Cameco’s 12-month high of $135.24 and low of $35.00 highlight its historical volatility, but the recent decline signals a potential reevaluation of its growth trajectory in light of Westinghouse’s challenges.

The lack of clarity in the administration’s nuclear strategy has amplified investor anxiety. With the Department of Energy engaging multiple stakeholders, including foreign entities like Korea Electric Power, the competitive landscape for Westinghouse—and by extension Cameco—remains fluid. The absence of a definitive timeline for resolving the Brookfield impasse or finalizing alternative partnerships has left investors in limbo, contributing to the stock’s sharp correction.

In summary, Cameco’s 6.4% drop reflects a confluence of sector-specific risks and broader market dynamics. The Trump administration’s nuclear policy pivot, coupled with the absence of cost-overrun insurance and stalled negotiations with Brookfield, has directly undermined investor confidence in Westinghouse and, by extension, Cameco’s strategic value. While the company’s uranium production fundamentals remain intact, the near-term outlook is clouded by regulatory and geopolitical uncertainties that will likely dictate its stock’s trajectory in the coming months.